Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Stock Information for 2seventy bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About 2seventy bio Inc.

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
Talphera Announces the Appointment of Joe Todisco to Board of Directors
CorMedix Announces Strategic Minority Investment in Talphera
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update
Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025
Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.